Dr. Olivia Aranha, MD

Dr. Aranha practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Aranha's NPI, 1386841211, was assigned on July 3, 2007. Dr. Aranha holds Missouri license 2009006298.

Dr. Aranha's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Aranha also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Aranha's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Aranha is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Aranha to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aranha practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Aranha's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Aranha is licensed in Missouri.

CMS data shows 15,890 Medicare services from Dr. Aranha across 27 procedure codes in 2024, for 289 Medicare patients. Medicare paid $404,283 for them.

CMS counts 289 Medicare patients who saw Dr. Aranha in 2024. The largest group is 65 to 74, with 153 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aranha's median patient age at 73, with 51% women.

In 2024, Dr. Aranha wrote 1,125 Medicare Part D claims for 138 patients. 86% of them were for generic drugs. CMS names the drug for 849 of them, across 25 drugs with 11 or more claims each, at $97,692 in total drug cost. In 2023, CMS named 875 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Aranha for performance year 2024, reported as part of a group. Dr. Aranha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Aranha, published from 2024 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell and Albumins. Dr. Aranha has published most often in Clin Cancer Res. Dr. Aranha's most frequent co-authors are Rama Suresh, MD, Katrina Sophia Pedersen, MD and Lee Ratner, MD.

Dmand AI links Dr. Aranha to 10 clinical trials, 4 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Anal Canal Carcinoma, Pancreatic Neoplasms and Anus Neoplasms. Washington University School of Medicine sponsors the most, 7.

CMS Open Payments shows 50 general payments to Dr. Aranha from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Seagen Inc. paid the most, $11,291.